I
MiNK Therapeutics D
D
INKT
0.75010
USD
-0.01
(-1.30%)
Market Closed
Volume
101
EPS
0
Div Yield
0
P/E
-2
Market Cap
29,658,721
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: MiNK Therapeutics
Sector: Healthcare
Industry: Biotechnology
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.